In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Geron Corp.. Trade Record

NASDAQ:GERN Geron Corp. stock gains 23.09% Exit Feb 8, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart GERN Jan 22, 2018, priceSeries
About Geron Corp.

Geron Corporation operates as a biopharmaceutical company. The company supports the clinical stage development of a telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
95.82
Entry Date
Jan 22, 2018
Entry Price
1.97
Sell Date
Feb 8, 2018
Sell Price
2.42
Net Gain
23.09%
Hold Time
13 Trading Days